news roundup
Grand View Research, Inc. released a new report with findings that predict the global clinical trial supplies market will reach $3.3 billion by 2025—a growth rate of 7.3%.
| advertisment
Clinical Trial Simulation: An Efficient Tool for Improved Study Designs, Dose Selection and Go/No-go Investment Decisions
Live Webcast: Tuesday, September 19 at 2:00pm BST and Thursday, September 28 at 10am EDT
 Register now |
The EU launched a call for proposals, backed with hard cash, for developing a European Health Data Network (EHDN), with the aim of gaining insight into real-world evidence and outcomes-focused healthcare services throughout Europe.
In our latest survey with our partner SCORR Marketing, many themes that have always concerned industry in regard to multi-regional clinical trials still ring true. While costs and patient population access are the primary drivers for conducting trials outside of the U.S. or Western Europe, the trade-off with good clinical practice (GCP), data quality, and language barriers still exist.
|
|
|
| advertisment
8th Clinical Quality Oversight Forum – October 11-13, Philadelphia
Join 150+ senior-level clinical quality, compliance and operations professionals to discuss strategies for ensuring trial integrity by effectively assessing, optimizing and managing the quality of clinical vendors and sites. Featured topics include ICH E6 R2, building a quality culture, inspection readiness, risk-based monitoring and auditing and more. Register by August 25 for maximum savings.
 CLICK HERE FOR MORE INFORMATION AND TO REGISTER. |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
Articles
This article will discuss the importance of good patient preparation, lead hook-up, and the quality checks that can be performed to ascertain that the ECG is of good quality.
Medium to large sponsors usually have in-house staff conducting CRO and vendor oversight with the guidance of their own company’s vendor selection and vendor oversight SOPs. Smaller companies typically do not have the resources to dedicate an employee or team of employees to this critical task.
|
|
|
Blog Posts
By using the patient and his or her journey as a starting point, manufacturers can create a more successful clinical trial designs while avoiding some common barriers.
While outsourcing increases, biopharma is still not realizing gains on process improvements. The author, from research marketplace Science Exchange expands on this lack of streamlined opportunity.
|
|
|
RBM
Tufts, CluePoints, and PWC organized a roundtable, which included senior executives from top tier pharmaceutical organizations that have responsibility for facilitating the changes required by the new ICH guidance to understand their challenges to achieve a common level of understanding across their organizations.
This peer-reviewed article provides an overview of FDA regulations paving the way for paperless trial success.
|
|
Upcoming RBM Events
CBI will host the Global Risk-Based Monitoring conference in Barcelona in mid-September. And, in the United States, CBI's Risk-Based Trial Management and Monitoring event will be held in Philadelphia the first week of November.
This free on-demand webcast offers an overview and understanding of the latest technology advancements for Centralized Monitoring, which provide insights into potential safety and performance issues.
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
